Cytophage Technologies Ltd. (TSXV:CYTO)
Canada · Delayed Price · Currency is CAD 0.0300
-0.0050 (-14.29%)
At close: May 15, 2026
Cytophage Technologies Market Cap
Cytophage Technologies has a market cap or net worth of CAD 2.03 million as of May 21, 2026. Its market cap has decreased by -77.85% in one year.
Market Cap
2.03M
Enterprise Value
2.85M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.03
Market Cap Chart
Since February 4, 2022, Cytophage Technologies's market cap has decreased from 5.25M to 2.03M, a decrease of -61.32%. That is a compound annual growth rate of -19.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 15, 2026 | 2.03M | -80.00% |
| Dec 31, 2025 | 10.15M | -36.19% |
| Dec 31, 2024 | 15.91M | 478.58% |
| Dec 23, 2022 | 2.75M | -47.62% |
| Feb 4, 2022 | 5.25M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PharmaTher Holdings | 5.92M |
| Restart Life Sciences | 5.64M |
| MYND Life Sciences | 5.22M |
| Doseology Sciences | 3.20M |
| BioVaxys Technology | 3.09M |
| Rakovina Therapeutics | 2.96M |
| ASEP Medical Holdings | 2.06M |
| Appili Therapeutics | 1.99M |